Photo: uk.investing.com
InspireMD Names Dr. Peter Soukas as New Chief Medical Officer
InspireMD appoints Dr. Peter Soukas as Chief Medical Officer to enhance its focus on the development of the CGuard Prime carotid stent system for stroke prevention.
- Dr. Peter A. Soukas, M.D., known for his expertise in Angiology, has been appointed as the Chief Medical Officer of InspireMD, Inc. effective immediately.
- InspireMD is recognized for its innovative CGuard Prime carotid stent system, aimed at addressing issues related to Peripheral artery disease and preventing Stroke.
- The company, based in Miami and valued at approximately $92 million, is preparing for its earnings release on November 4, alongside its ongoing efforts in Interventional radiology.
Why It Matters
The appointment of Dr. Soukas as Chief Medical Officer underscores InspireMDs commitment to advancing technologies in Blood vessel health, particularly in the Common carotid artery, which is crucial for stroke prevention.